V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280007295 | 280004600 | 1.73 | 102 | Palliative (P) | null | 2018-04-25 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280023991 | CISPLATIN + RT |
| 280007296 | 280004600 | 1.72 | 72.4 | Palliative (P) | 2016-09-08 | 2016-09-08 | Trabectedin | N | N | 280023991 | TRABECTEDIN |
| 280007297 | 280004600 | 1.78 | 117 | Curative (C) | 2017-08-05 | 2017-08-31 | Cisplatin 100 + RT(H&N) 1 day | N | N | 280023991 | CISPLATIN + RT |
| 280007298 | 280004601 | null | 83.75 | Palliative (P) | 2017-04-15 | 2017-04-16 | Trabectedin | 02 | N | 280024017 | TRABECTEDIN |
| 280007299 | 280004603 | 1.93 | 68.8 | Curative (C) | 2017-09-16 | 2017-09-28 | Cisplatin 100 + RT(H&N) 1 day | N | N | 280024037 | CISPLATIN + RT |
| 280007300 | 280004603 | 1.8 | 57.8 | Palliative (P) | 2017-11-04 | 2017-11-25 | Trabectedin | 02 | N | 280024037 | TRABECTEDIN |
| 280007301 | 280004604 | 1.82 | 60.4 | Palliative (P) | 2017-07-06 | 2017-11-16 | Trabectedin | N | Y | 280024045 | TRABECTEDIN |
| 280007302 | 280004605 | 1.68 | null | Curative (C) | 2016-06-10 | 2016-07-15 | Cisplatin 100 + RT(H&N) 1 day | N | N | 280024055 | CISPLATIN + RT |
| 280007303 | 280004606 | null | 46 | Curative (C) | 2017-05-08 | 2017-05-08 | CISPLATIN + RT | 2 | Y | 280024058 | CISPLATIN + RT |
| 280007304 | 280004607 | 1.92 | null | Palliative (P) | null | 2016-05-10 | LUX TRIAL | Y | null | 280024062 | TRIAL |
| 280007305 | 280008455 | 1.65 | 76 | Palliative (P) | 2018-06-22 | 2018-06-22 | Trabectedin | 02 | Y | 280024063 | TRABECTEDIN |
| 280007306 | 280010275 | 0 | 66.6 | Disease modification (D) | 2015-11-22 | 2016-01-28 | Trabectedin | 02 | N | 280024064 | TRABECTEDIN |
| 280007307 | 280010276 | 1.76 | 67.4 | Curative (C) | 2015-01-03 | 2015-02-23 | Cisplatin + Radiotherapy | N | N | 280024068 | CISPLATIN + RT |
| 280007308 | 280004609 | 1.72 | 91.6 | Disease modification (D) | 2014-05-15 | 2014-05-22 | EW EuroEwing 2012 Arm B IE | 02 | Y | 280024072 | TRIAL |
| 280007309 | 280004610 | 1.92 | null | Curative (C) | 2014-09-23 | 2014-09-23 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280024081 | CISPLATIN + RT |
| 280007310 | 280008458 | 1.84 | 71.7 | Curative (C) | 2014-10-25 | 2015-05-06 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 280024086 | CISPLATIN + RT |
| 280007311 | 280004611 | null | 129.3 | Curative (C) | 2013-02-15 | 2013-07-22 | Cisplatin + Radiotherapy | N | null | 280024089 | CISPLATIN + RT |
| 280007312 | 280004613 | 1.75 | 67.4 | Adjuvant (A) | 2016-08-29 | 2016-10-21 | Trial Unspecified | 1 | N | 280024096 | TRIAL |
| 280007313 | 280004613 | 1.7 | 55.9 | null | 2014-12-25 | 2015-03-22 | Carboplatin AUC 2 - 5 | 02 | null | 280024096 | CARBOPLATIN |
| 280007314 | 280004613 | 1.77 | null | Curative (C) | 2017-10-20 | 2017-12-01 | Cisplatin + Docetaxel +Fluorouracil | Y | null | 280024096 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007315 | 280004615 | 1.78 | null | Curative (C) | 2017-05-27 | 2017-08-20 | Carboplatin AUC 2 - 5 | N | null | 280024109 | CARBOPLATIN |
| 280007316 | 280004615 | null | 55.2 | null | 2014-11-01 | 2014-11-09 | Cetuximab 7 day (>Cycle 2) | N | Y | 280024109 | CETUXIMAB |
| 280007317 | 280004616 | 1.79 | null | Neo-adjuvant (N) | 2015-04-26 | 2015-04-26 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | 280024112 | DOCETAXEL + GEMCITABINE |
| 280007318 | 280004616 | 1.65 | 69.4 | Curative (C) | 2017-03-25 | 2017-04-10 | NB HRNBL-1 TVD | 02 | N | 280024112 | NOT MATCHED |
| 280007319 | 280004617 | 1.76 | 93.1 | Not known (9) | 2017-10-18 | 2017-10-23 | Carboplatin AUC 6 - 10 | 02 | Y | 280024121 | CARBOPLATIN |
| 280007320 | 280004618 | 0 | 80.4 | Curative (C) | 2017-05-18 | 2017-06-14 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | null | null | 280024122 | NOT MATCHED |
| 280007321 | 280008464 | null | 73.4 | Curative (C) | 2015-05-11 | 2015-06-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280024124 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007322 | 280004619 | 1.61 | null | Curative (C) | 2017-04-22 | 2017-05-02 | Cetuximab 7 day (>Cycle 2) | N | N | 280024138 | CETUXIMAB |
| 280007323 | 280004620 | 1.61 | 85.999 | Curative (C) | 2017-09-10 | 2017-10-17 | Cetuximab 7 day (>Cycle 2) | null | null | 280024138 | CETUXIMAB |
| 280007324 | 280010280 | 1.63 | 113.7 | Neo-adjuvant (N) | 2016-02-09 | 2016-02-29 | Docetaxel + Gemcitabine (prior RT) | N | null | 280024141 | DOCETAXEL + GEMCITABINE |
| 280007325 | 280008466 | 1.75 | null | Curative (C) | null | 2017-11-07 | Cetuximab 7 day (>Cycle 2) | N | Y | 280024146 | CETUXIMAB |
| 280007326 | 280004622 | null | 58.55 | Neo-adjuvant (N) | 2017-05-14 | 2017-05-22 | Docetaxel + Gemcitabine with GCSF | N | null | 280024146 | DOCETAXEL + GEMCITABINE |
| 280007327 | 280011872 | 1.52 | 106.7 | Not known (9) | 2016-10-10 | 2016-10-10 | Carboplatin AUC 2 - 5 | 02 | null | 280024153 | CARBOPLATIN |
| 280007328 | 280004623 | 1.8 | 48.3 | Curative (C) | 2015-07-09 | 2015-07-16 | CETUXIMAB | 2 | Y | 280024161 | CETUXIMAB |
| 280007329 | 280004624 | 1.7 | 81.2 | Neo-adjuvant (N) | 2015-02-06 | 2015-03-09 | Docetaxel + Gemcitabine (prior RT) | 02 | Y | 280024163 | DOCETAXEL + GEMCITABINE |
| 280007330 | 280008468 | 1.69 | 93.1 | Palliative (P) | 2017-11-30 | 2017-12-06 | Docetaxel + Gemcitabine (prior RT) | N | Y | 280024172 | DOCETAXEL + GEMCITABINE |
| 280007331 | 280004625 | null | 85 | Curative (C) | 2017-02-03 | 2017-02-11 | Carboplatin AUC 2 - 5 | 02 | Y | 280024176 | CARBOPLATIN |
| 280007332 | 280004626 | 1 | 79.6 | Curative (C) | 2013-09-07 | 2014-02-25 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | 280024184 | NOT MATCHED |
| 280007333 | 280004628 | 1.7 | 78.7 | Curative (C) | 2015-02-25 | 2015-02-25 | Carboplatin AUC 6 - 10 | 2 | N | 280024184 | CARBOPLATIN |
| 280007334 | 280004628 | null | 82.2 | Curative (C) | 2016-02-21 | 2016-02-21 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | Y | 280024184 | NOT MATCHED |
| 280007335 | 280004630 | 0 | 95 | null | null | 2017-04-05 | STS Rhabdo RMS 2005 | 02 | null | 280024198 | NOT MATCHED |
| 280007336 | 280004633 | 1.8 | 14.2 | Curative (C) | 2017-06-13 | 2017-07-10 | CETUXIMAB | 01 | null | 280024204 | CETUXIMAB |
| 280007337 | 280008472 | 1.66 | 9.8 | Curative (C) | 2013-06-02 | 2013-09-04 | Carboplatin AUC 2 - 5 | N | null | 280024214 | CARBOPLATIN |
| 280007338 | 280004634 | 1.81 | 51.3 | Curative (C) | 2016-11-07 | 2016-12-24 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280024231 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007339 | 280004634 | 1.6 | null | Curative (C) | 2017-01-30 | 2017-04-05 | CETUXIMAB | 02 | N | 280024231 | CETUXIMAB |
| 280007340 | 280004636 | 1.63 | 57.9 | Disease modification (D) | 2016-03-23 | 2016-09-18 | EW EuroEwing 2012 Arm B VC | N | Y | 280024237 | NOT MATCHED |
| 280007341 | 280010285 | null | 69.8 | Curative (C) | 2015-07-14 | 2015-08-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 280024237 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007342 | 280004639 | 1.8 | 98.1 | Neo-adjuvant (N) | null | 2016-06-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280024243 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007343 | 280011186 | 1.61 | null | Curative (C) | 2015-09-08 | 2015-10-06 | CETUXIMAB | Y | Y | 280024263 | CETUXIMAB |
| 280007344 | 280004641 | null | null | Adjuvant (A) | 2016-08-02 | 2016-08-03 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | N | 280024275 | NOT MATCHED |